相似文献
1
Challenges in monitoring the quality of care in multiple sclerosis.
Lancet Reg Health Eur. 2024 May 25;42:100950. doi: 10.1016/j.lanepe.2024.100950. eCollection 2024 Jul.
2
What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.
Neurol Ther. 2023 Oct;12(5):1419-1429. doi: 10.1007/s40120-023-00519-z. Epub 2023 Jul 19.
3
Patient perspectives on patient-reported outcomes in multiple sclerosis treatment trajectories: A qualitative study of why, what, and how?
Mult Scler Relat Disord. 2022 Feb;58:103475. doi: 10.1016/j.msard.2021.103475. Epub 2021 Dec 27.
4
Challenges in multiple sclerosis care: Results from an international mixed-methods study.
Mult Scler Relat Disord. 2021 May;50:102854. doi: 10.1016/j.msard.2021.102854. Epub 2021 Feb 23.
5
A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol.
BMC Neurol. 2015 Aug 4;15:128. doi: 10.1186/s12883-015-0379-0.
6
Consensus quality indicators for monitoring multiple sclerosis.
Lancet Reg Health Eur. 2024 Mar 29;40:100891. doi: 10.1016/j.lanepe.2024.100891. eCollection 2024 May.
7
Factors affecting MS patients' health-related quality of life and measurement challenges in Lebanon and the MENA region.
Mult Scler J Exp Transl Clin. 2020 Jan 9;6(1):2055217319848467. doi: 10.1177/2055217319848467. eCollection 2020 Jan-Mar.
8
Challenges of patients with multiple sclerosis in receiving health care services in Iran.
Curr J Neurol. 2023 Jan 5;22(1):16-22. doi: 10.18502/cjn.v22i1.12612.
9
The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.
BMC Neurol. 2018 Aug 13;18(1):111. doi: 10.1186/s12883-018-1118-0.
10
Medical Therapeutic Yoga for multiple sclerosis: examining self-efficacy for physical activity, motivation for physical activity, and quality of life outcomes.
Disabil Rehabil. 2022 Jan;44(1):106-113. doi: 10.1080/09638288.2020.1760364. Epub 2020 May 12.
引用本文的文献
1
Challenges in monitoring the quality of care in multiple sclerosis-authors' reply.
Lancet Reg Health Eur. 2024 May 27;42:100951. doi: 10.1016/j.lanepe.2024.100951. eCollection 2024 Jul.
本文引用的文献
1
Consensus quality indicators for monitoring multiple sclerosis.
Lancet Reg Health Eur. 2024 Mar 29;40:100891. doi: 10.1016/j.lanepe.2024.100891. eCollection 2024 May.
2
Multiple Sclerosis Diagnostic Delay and Misdiagnosis.
Neurol Clin. 2024 Feb;42(1):1-13. doi: 10.1016/j.ncl.2023.07.001.
3
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies.
Curr Neurol Neurosci Rep. 2023 Sep;23(9):521-529. doi: 10.1007/s11910-023-01289-9. Epub 2023 Jul 31.
4
Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis.
Int J MS Care. 2021 Jan-Feb;23(1):37-44. doi: 10.7224/1537-2073.2020-026. Epub 2021 Feb 23.
5
What We Learned from The History of Multiple Sclerosis Measurement: Expanded Disability Status Scale.
Noro Psikiyatr Ars. 2018;55(Suppl 1):S69-S75. doi: 10.29399/npa.23343.
Zotero 插件